...
首页> 外文期刊>Ecological restoration >Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature
【24h】

Non-invasive brain stimulation modalities for the treatment and prevention of opioid use disorder: a systematic review of the literature

机译:非侵袭性脑刺激型号治疗和预防阿片类药物使用障碍:对文献的系统审查

获取原文
获取原文并翻译 | 示例
           

摘要

The U.S. is currently facing an unprecedented epidemic of opioid-related deaths. Despite the efficacy of the current treatments for opioid use disorder (OUD), including psychosocial interventions and medication-assisted therapy (MAT), many patients remain treatment-resistant and at high risk for overdose. A potential augmentation strategy includes the use of non-invasive brain stimulation (NIBS) techniques, such as transcranial magnetic stimulation (TMS), transcranial direct current stimulation (tDCS), and auricular vagus nerve stimulation (aVNS). These approaches may have therapeutic benefits by directly or indirectly modulating the neurocircuitry affected in OUD. In this review, we evaluate the available studies on NIBS in the context of OUD withdrawal and detoxification, maintenance, and cravings, while also considering analgesia and safety concerns. In the context of opioid withdrawal and detoxification, a percutaneous form of aVNS has positive results in open-label trials, but has not yet been tested against sham. No randomized studies have reported on the safety and efficacy of NIBS specifically for maintenance treatment in OUD. TMS and tDCS have demonstrated effects on cravings, although published studies were limited by small sample sizes. NIBS may play a role in reducing exposure to opioids and the risk of developing OUD, as demonstrated by studies using tDCS in an experimental pain condition and TMS in a post-operative setting. Overall, while the preliminary evidence and safety for NIBS in the prevention and treatment of OUD appears promising, further research is needed with larger sample sizes, placebo control, and objective biomarkers as outcome measures before strong conclusions can be drawn.
机译:美国目前正面临前所未有的与阿片类药物相关的死亡流行病。尽管目前对阿片类药物使用障碍(Oud)的治疗方法,包括心理社会干预和药物辅助治疗(MAT),但许多患者仍然抗治疗,并且高过量风险。潜在的增强策略包括使用非侵入性脑刺激(NIBS)技术,例如经颅磁刺激(TMS),经颅导流刺激(TDC)和耳廓迷走神经刺激(AVN)。这些方法可以通过直接或间接调节在oud中受影响的神经核来进行治疗益处。在本次审查中,我们在响应和排毒,维护和渴望的背景下评估了关于尖端的可用研究,同时考虑镇痛和安全问题。在阿片类药物戒断和排毒的背景下,经皮的AVN的阳性结果在开放标签试验中具有阳性结果,但尚未对假的进行测试。没有随机研究报告了尖端的安全性和有效性,特别是在oud中进行维持治疗。尽管公布的研究受到小样本尺寸的限制,但TMS和TDCS对渴望的影响表现出了对渴望的影响。在通过在操作后环境中的实验性疼痛条件和TMS中,通过研究证明,NIBs可能在减少对阿片类药物和开发oud的风险的作用以及在操作后设定中的实验性疼痛条件和TMS所证明的情况下发挥作用。总体而言,虽然在预防和治疗oud的初步证据和安全性似乎有希望,但需要更大的样本尺寸,安慰剂对照和客观生物标志物,因为在强烈结论之前,可以进行更大的样本尺寸,安慰剂控制和客观的生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号